// App-Quantinova.ai

OP0124 (2018) : In sle patients in sustained low disease activity, novel interferon assays predict flares and glucocorticoid requirements

Researchers

Presenter

  • K. Dutton

Principal Investigators

  • A. Psarras

  • Y. El-Sherbiny

  • M.Y. Md Yusof

  • P. Emery

  • E. Vital

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Bone marrow stromal antigen 2

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 38

  • Cluster of Differentiation 19

  • Interferon-alpha

Drug/Treatment

  • Glucocorticoid

  • Interferon

  • DLP201

  • Rituximab

  • IFN-lambda

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved